Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE ...

The Ahmedabad-based pharmaceutical firm's shares listed at Rs 600 on the National Stock Exchange, a premium of 53.45%.

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

Senores Pharmaceuticals Ltd witnessed a stellar debut on stock exchanges, with shares surging nearly 43% against the issue ...

Senores Pharmaceuticals Ltd had a successful IPO, with shares surging over 53% from the issue price of Rs 391. The company's market valuation hit Rs 2,657.29 crore. The proceeds will aid in expanding ...

Senores Pharmaceuticals share price listed at stellar 53% premium at ₹600 on the NSE and ₹593.70 on the BSE on Monday ...

Senores Pharmaceuticals shares opened at Rs 600 on the National Stock Exchange at a premium of 53.45% over its IPO price of ...

Senores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's website. The IPO saw a robust subscription of over 93.41 times, ...

Senores Pharmaceuticals IPO share allotment status is likely to be finalised on Thursday, Dec. 26, following a robust subscription. The initial public offering of the pharmaceutical company was ...

Senores Pharmaceuticals Ltd is expected to finalise the share allotment status for its initial public offering (IPO) on Thursday, December 26, after the issue closed with a robust subscription. The ...